• OPEN AN ACCOUNT
Indian Indices
Sensex
81,592.45 -318.56
( -0.39%)
Global Indices
Nasdaq
52,349.65 31.56
(0.06%)
Dow Jones
7,578.06 -35.34
(-0.46%)
Hang Seng
61,109.24 289.88
(0.48%)
Nikkei 225
10,906.25 43.16
(0.40%)
Forex
USD-INR
93.72 0.15
(0.16%)
EUR-INR
104.27 -0.51
(-0.49%)
GBP-INR
124.72 -0.66
(-0.52%)
JPY-INR
0.59 0.00
(-0.43%)

EQUITY - MARKET SCREENER

Tata Steel Ltd
Industry :  Steel - Large
BSE Code
ISIN Demat
Book Value()
500470
INE081A01020
131.9509386
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
TATASTEEL
12.47
233441.96
EPS(TTM)
Face Value()
Div & Yield %
14.99
1
2.14
 

Symbiotec Pharmalab surges after Pithampur facility gets EIR from US FDA
Sep 29,2026

The American drug regulatory has issued the said EIR report with a voluntary action indicated (VAI) status.

The US FDA had conducted an inspection at the company’s manufacturing facility at Pithampur, from 10 August 2026 to 14 August 2026.

Symbiotec Pharmalab is a research and development-driven, science-based pharmaceutical and biotechnology company with capabilities across organic chemistry, biotechnology and complex injectables.

The company had reported 52.8% fall in consolidated net profit to Rs 14.1 crore despite a 7% rise in revenue from operations to Rs 218.2 crore in Q1 FY27 as compared with Q1 FY26.